TCL Archive In Brief: Surgeons Oncology Group Gets NCI Funding To Conduct Multicenter Clinical Trials April 17, 1998
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012